Generic Pharmaceutical Association - Citizen Petition
| || |
Show More Details
Date Posted: Sep 19, 2013
Country: United States
Category: Private Industry - C0003
The FDAs approval on March 6 of Zarxio (filgrastim-sndz) heralds a new era for cancer patients and the American health care system, one where safe, affordable...
Comments of Mylan, Inc. in support of the Citizen Petitions submitted by the Generic Pharmaceutical Association and the Novartis Group of companies requesting...
This document is contained in
Related Dockets: FDA-2015-N-0648
Related RINs: None
* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.